Sujal Shah - 13 Mar 2024 Form 4 Insider Report for CymaBay Therapeutics, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Sujal Shah
Issuer symbol
N/A
Transactions as of
13 Mar 2024
Net transactions value
+$655,959
Form type
4
Filing time
15 Mar 2024, 16:03:54 UTC
Previous filing
26 Jan 2024
Next filing
22 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBAY Common Stock Options Exercise $116,490 +11,649 +4.4% $10.00 279,200 13 Mar 2024 Direct
transaction CBAY Common Stock Options Exercise $15,502 +14,625 +5.2% $1.06* 293,825 13 Mar 2024 Direct
transaction CBAY Common Stock Options Exercise $89,584 +52,084 +18% $1.72* 345,909 13 Mar 2024 Direct
transaction CBAY Common Stock Options Exercise $174,060 +18,899 +5.5% $9.21 364,808 13 Mar 2024 Direct
transaction CBAY Common Stock Options Exercise $36,531 +3,125 +0.86% $11.69 367,933 13 Mar 2024 Direct
transaction CBAY Common Stock Options Exercise $121,156 +14,372 +3.9% $8.43 382,305 13 Mar 2024 Direct
transaction CBAY Common Stock Options Exercise $89,408 +22,076 +5.8% $4.05 404,381 13 Mar 2024 Direct
transaction CBAY Common Stock Options Exercise $13,225 +2,288 +0.57% $5.78 406,669 13 Mar 2024 Direct
transaction CBAY Common Stock Options Exercise $2.94 +1 +0% $2.94 406,670 13 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -11,649 -100% $0.000000* 0 13 Mar 2024 Common Stock 11,649 $10.00 Direct F1
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -14,625 -100% $0.000000* 0 13 Mar 2024 Common Stock 14,625 $1.06 Direct F1
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -52,084 -100% $0.000000* 0 13 Mar 2024 Common Stock 52,084 $1.72 Direct F1
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -18,899 -100% $0.000000* 0 13 Mar 2024 Common Stock 18,899 $9.21 Direct F2
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -3,125 -100% $0.000000* 0 13 Mar 2024 Common Stock 3,125 $11.69 Direct F3
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -14,372 -100% $0.000000* 0 13 Mar 2024 Common Stock 14,372 $8.43 Direct F4
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -22,076 -100% $0.000000* 0 13 Mar 2024 Common Stock 22,076 $4.05 Direct F5
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -2,288 -15% $0.000000 12,845 13 Mar 2024 Common Stock 2,288 $5.78 Direct F6
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -1 -0% $0.000000 35,799 13 Mar 2024 Common Stock 1 $2.94 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/4 of the underlying shares on the first anniversary of the grant date, and vests as to 1/48 of the underlying shares monthly thereafter.
F2 The option vests as to 1/48 of the underlying shares monthly from October 27, 2017.
F3 The option vests as to 1/4 of the underlying shares on January 1, 2019, and vests as to 1/48 of the underlying shares monthly thereafter.
F4 The option vests as to 1/4 of the underlying shares on January 1, 2020, and vests as to 1/48 of the underlying shares monthly thereafter.
F5 The option vests as to 1/48 of the underlying shares monthly from January 31, 2020.
F6 The option vests as to 1/48 of the underlying shares monthly from January 1, 2021.
F7 The option vests as to 1/48 of the underlying shares monthly from January 1, 2022.